Regulation of cholesterol biosynthesis in rat liver after the administration of N-2-fluorenylacetamide.
D000081:Acetamides / Q000494:pharmacology; D000085:Acetates / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D002784:Cholesterol / Q000032:analysis / Q000096:biosynthesis*; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D003470:Culture Media; D004952:Esters / Q000032:analysis; D005449:Fluorenes / Q000494:pharmacology*; D006965:Hyperplasia; D006984:Hypertrophy; D008099:Liver / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D008113:Liver Neoplasms / Q000378:metabolism; D008297:Male; D008798:Mevalonic Acid / Q000378:metabolism; D008862:Microsomes, Liver / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D011230:Precancerous Conditions / Q000378:metabolism; D051381:Rats; D013997:Time Factors; D014316:Tritium
D000081:Acetamides; D000085:Acetates; D002247:Carbon Isotopes; D002791:Cholesterol, Dietary; D003470:Culture Media; D004952:Esters; D005449:Fluorenes; D014316:Tritium; D002784:Cholesterol; D008798:Mevalonic Acid